Navigation Links
DeBakey VAD

ProductsDeBakey VAD
Company Micromed s.r.l.
Item DeBakey VAD
Features 
  • Miniaturized size and light weight: About 1/10 the size of competitive pulsatile VAD products on the market and weighing less than four ounces, the MicroMed DeBakey VAD measures 1" x 3". This smaller size gives a treatment hope to those with smaller body types, such as petite women and children, because larger devices cannot be implanted in them. The small size of the device and flexible percutaneous cable should also provide lower infection rates.
  • Reduced surgical time: Our current experience shows surgical time to be 1 hours, about one-half the time of implanting pulsatile devices.
  • Cost: The MicroMed DeBakey VAD is projected to be 1/3 less expensive than currently marketed pulsatile VADs, making the process more affordable to a wider group of patients.
  • Reduced complications: The device's potential for decreased rates of hemolysis and thromboembolic complications improves the safety of the MicroMed DeBakey VAD for patients
  • Simplicity of design: The device only contains one moving part, the inducer/impeller. Third party studies project that the mechanical durability will last in excess of five years.
  • Patient quality of life: The MicroMed DeBakey VAD is virtually silent when compared to other devices, improving patient comfort while on the device. Additionally, the VADPAK enables patient mobility to preserve quality of life.
Description The MicroMed DeBakey VAD is a miniaturized heart pump designed to provide increased blood flow (up to 10L/min) from the left ventricle of the heart throughout the body for patients in end stage heart failure.
Info Micromed s.r.l.
Customer Service: 39.041.5937000
Web site: http://www.micromed-it.com/

Related medicine products :

1. BD Beaver DeBakey blade
2. DeBakey Forceps
3. Babcock-DeBakey Forceps
Stryker Endoscopy has combined a standardized pressurizing system with an advanced hand piece design that is lightweight and compact in order to streamline laparoscopic procedures....
... invasive, highly effective surgical alternative for the ... is positioned close to the high pressure ... TVT provides tension-free support of the urethra ... approximately 20 to 30 minutes, with minimal ...
... to treatment is accurate diagnosis of the ... quick, patient-friendly tool designed to aid in ... minimizing patient discomfort. Designed for in-office use, ... type of urethral pressure measurement for stress ...
...
Medicine Products:
(Date:5/27/2016)... ... 27, 2016 , ... More than a third of American adults are considered ... surgery has received increased attention in recent years, as an article published ... weight loss, most people are familiar with the basic requirements of maintaining a healthy ...
(Date:5/27/2016)... ... ... With over 60 percent of acute stroke survivors being left unable to ... in the rehabilitation process has steadily increased. Ekso Bionics had been working to help ... stroke. , Ekso Bionics has now received clearance from the U.S. Food and Drug ...
(Date:5/27/2016)... ... May 27, 2016 , ... Aimed ... by inspiring human interest stories, courtesy of leaders in the nursing and health ... the industry, from leading advocates and associations—namely Jones & Bartlett Learning. , Jones ...
(Date:5/26/2016)... ... ... There are many ways to cook a hot dog, but new research commissioned ... dogs straight off the grill. Of the 90 percent of Americans who say they ... hot dog, far outpacing other cooking methods such as steaming (12 percent), microwaving (9 ...
(Date:5/26/2016)... , ... May 26, 2016 , ... Connor Sports, ... basketball as a partner for the Tamika Catchings Legacy Tour that will ... industry leader in hardwood basketball surfaces in all forms and levels of the game, ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... MedDay, a biotechnology company focused on the treatment ... "High doses of biotin in progressive multiple sclerosis: extension phase ... Ayman Tourbah , Principal Investigator of the Phase 3 ... Neurology (EAN) in Copenhagen, Denmark . The ... on Sunday, 29 May 2016 from 14:45 to 16:15 CEST ...
(Date:5/24/2016)... --   , ... Endpunkte und demonstriert Ebenbürtigkeit bei der Gesamtreinigung des ... guter , Reinigung des ... (Logo: http://photos.prnewswire.com/prnh/20130829/633895-a ) , ... der MORA-Studie der Phase III für NER1006 (1 ...
(Date:5/24/2016)... Celsion Corporation (NASDAQ: CLSN ... an update on its ongoing OVATION study, a ... the Company,s DNA-based immunotherapy, with the standard of ... advanced ovarian cancer who will undergo neoadjuvant chemotherapy ... IL-12 DNA plasmid vector formulated as a nanoparticle ...
Breaking Medicine Technology: